UA97073U - Integrated dual method of treatment of pathological dependence on alcohol and stimulants aralia - Google Patents
Integrated dual method of treatment of pathological dependence on alcohol and stimulants araliaInfo
- Publication number
- UA97073U UA97073U UAU201410958U UAU201410958U UA97073U UA 97073 U UA97073 U UA 97073U UA U201410958 U UAU201410958 U UA U201410958U UA U201410958 U UAU201410958 U UA U201410958U UA 97073 U UA97073 U UA 97073U
- Authority
- UA
- Ukraine
- Prior art keywords
- aralia
- stimulants
- alcohol
- treatment
- integrated dual
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 241000722818 Aralia Species 0.000 title abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title abstract 2
- 230000009977 dual effect Effects 0.000 title abstract 2
- 230000001575 pathological effect Effects 0.000 title abstract 2
- 239000000021 stimulant Substances 0.000 title abstract 2
- 238000001467 acupuncture Methods 0.000 abstract 1
- 238000001784 detoxification Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000002443 hepatoprotective effect Effects 0.000 abstract 1
- 238000011422 pharmacological therapy Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Integrated dual method of treatment of pathological dependence on alcohol and stimulants Aralia provides comprehensive standard detoxification, symptomatic, antykrevinhovu, hepatoprotective, immune correcting pharmacological therapy combined with classical reflexology. Patient in addition to the basic set of prescribed therapeutic sessions microwave resonance therapy (MRT); elektroaurykuloterapiyi sessions; braking technique while using classical acupuncture; and drug antykonvulsyvnoyi and tymoleptychnoyi action.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201410958U UA97073U (en) | 2014-10-07 | 2014-10-07 | Integrated dual method of treatment of pathological dependence on alcohol and stimulants aralia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201410958U UA97073U (en) | 2014-10-07 | 2014-10-07 | Integrated dual method of treatment of pathological dependence on alcohol and stimulants aralia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA97073U true UA97073U (en) | 2015-02-25 |
Family
ID=63013245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201410958U UA97073U (en) | 2014-10-07 | 2014-10-07 | Integrated dual method of treatment of pathological dependence on alcohol and stimulants aralia |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA97073U (en) |
-
2014
- 2014-10-07 UA UAU201410958U patent/UA97073U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY174727A (en) | Stable, protracted glp-1/glucagon receptor co-agonists for medical use | |
| CL2018000706A1 (en) | Derivatives of pyrazolopyrimidine as btk inhibitors for the treatment of cancer. | |
| NZ756730A (en) | Combination therapy with an anti-axl antibody-drug conjugate | |
| MX2020004023A (en) | Use of a pcsk9 inhibitor to treat hyperlipidemia. | |
| CL2015002691A1 (en) | Myostatin antagonist in human subjects | |
| PH12015500246A1 (en) | Pharmaceutical combinations comprising a b-raf inhibitor, an egfr inhibitor and optionally a pi3k-alpha inhibitor | |
| MX2017015896A (en) | Anticancer agent. | |
| PH12017500392A1 (en) | Medical treatments based on anamorelin | |
| HK1250626A1 (en) | Combination treatments with seribantumab | |
| MX2020001727A (en) | Combination therapy. | |
| MX379201B (en) | 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives | |
| MX2016000220A (en) | Regulation of glucose metabolism using anti-cgrp antibodies. | |
| WO2011100769A3 (en) | Kinase modulators for the treatment of cancer | |
| GB2554591A (en) | Clinical support system and method | |
| MY197942A (en) | Adjuvant therapy for use in prostate cancer treatment | |
| UA97073U (en) | Integrated dual method of treatment of pathological dependence on alcohol and stimulants aralia | |
| MX2019014988A (en) | Method for reducing or preventing cardiovascular events in patients with type ii diabetes mellitus. | |
| MX2018011607A (en) | Sultiame for the treatment of sleep apnea. | |
| UA90706U (en) | Method for medicamentous correction of the impaired production of nitric oxide in treating diabetic nephropathy | |
| CN105521549A (en) | Medicine applying device for treating beriberi | |
| MX2023006765A (en) | Method of providing celiprolol therapy to a patient. | |
| WO2014155268A3 (en) | Fgf-r tyrosine kinase activity inhibitors - use in diseases associated with lack of or reduced snf5 activity | |
| UA93178U (en) | Method for treating chronic tonsillitis in children | |
| Gu et al. | Progress on methodology of adjusting survival curves | |
| UA88769U (en) | Method for preventing and treating benign breast dysplasia in patients with early miscarriage |